In the medical industry, translation is not merely a linguistic task, but a critical component of a broader regulatory and operational system. Documentation must be accurate, consistent, and traceable across all languages, as it directly impacts compliance, patient safety, and speed to market. Despite this, many organizations still evaluate translation primarily through the lens of cost per word.
This approach is misleading.
Not because cost is unimportant, but because it does not reflect the actual expense incurred throughout the entire documentation lifecycle. That cost almost never becomes visible during the translation phase itself, but rather later during reviews, alignment processes, and regulatory procedures.
When a translation is not properly prepared from the outset, problems do not emerge as isolated incidents. Even a minor terminology inconsistency or a slightly unclear formulation can trigger a broader wave of corrections. Medical documentation is not a collection of unrelated files, but an interconnected system in which clinical texts, instructions for use, labeling, and regulatory documents are all interdependent.
As a result, corrections rarely remain localized.
When one term or interpretation changes, consistency must be ensured across all related documents. This requires additional reviews, revalidation, and often the involvement of multiple departments, from regulatory affairs and quality assurance to medical experts. Each additional step extends timelines and increases management complexity.
Rework therefore quickly evolves from a technical correction into a process issue.
In a regulated environment, the consequences are even greater. Every change may require another review cycle, additional documentation of decisions, and in some cases, delays in regulatory submissions. This directly impacts approval timelines and, consequently, the product’s time to market.
The business impact is multifaceted:
• extended timelines and approval delays
• increased costs due to repetitive work
• greater burden on internal teams
• reduced project predictability
The biggest mistake in addressing this issue is assuming that it is primarily a matter of the quality of an individual translation. In reality, it is a matter of process design.
If the process is not structured, if terminology is not managed consistently, and if there are no built-in mechanisms for early risk detection, organizations inevitably slip into a reactive mode of operation. In such an environment, teams spend most of their time correcting and aligning issues rather than building a stable and predictable system.
The key difference between organizations that successfully control rework and those that continually struggle with it lies in when they begin focusing on quality.
In high-performing teams, quality is not checked at the end, but built in from the beginning. This means that terminology, style, and context are clearly defined before translation even starts. It also means that processes are designed to systematically reduce the likelihood of errors rather than relying on their detection later.
Such an approach includes thoughtful terminology management, structured multi-stage reviews, and clearly defined responsibilities throughout the process. Another important element is the early identification of linguistic and regulatory risks before they develop into actual issues.
The result is not simply a better translation, but a significantly more efficient process.
Organizations that successfully reduce rework achieve tangible advantages:
• faster and more predictable regulatory approvals
• lower overall costs throughout the entire process
• shorter time to market
• reduced burden on internal teams
This transforms translation into a strategic element of operational efficiency rather than a narrowly defined cost.
Ultimately, the decision is not between a “cheaper” and a “more expensive” translation. It is a choice between a process that generates additional work and one that systematically prevents it.
The difference between these two approaches is directly reflected in a company’s competitiveness, in its ability to operate quickly, efficiently, and compliantly across multiple markets simultaneously.
How does your team currently manage the risk of rework in medical translation?
Contact us at info@translat.si to learn more.